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Abstract 
In Drosophila, a novel target of the Epidermal Growth Factor Receptor (EGFR) signaling 
pathway, CG4096 was identified using microarray analysis. The gene belongs to the family of 
ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) proteins, which 
are involved in regulating components of the extracellular matrix (ECM). Tissue culture cells 
(S2) that stably express Drosophila EGFR under an inducible promoter (S2-DER II) were used 
to test whether induction can be demonstrated in vitro. Examining expression using Reverse 
transcription-PCR analysis of S2-DER cells showed that CG4096 was induced, confirming the 
microarray data. In order to analyze the function of CG4096, a loss of function mutant is being 
generated by remobilizing a transposable element inserted in the gene. Due to conservation, 
analyzing the phenotype of a CG4096 Drosophila mutant will likely shed light on the role of 
ADAMTS genes in vertebrates. This is important because the genes are implicated in multiple 
disease processes. 
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Introduction 
 
The epidermal growth factor receptor (EGFR) pathway is a highly conserved cell 
signaling pathway that is required for cell proliferation, differentiation, migration and survival 
during the development of an organism— including vertebrates and Drosophila1. Drosophila 
melanogaster, serves as a model organism for studying EGFR signaling because there is only 
one epidermal growth factor receptor in the fruit fly compared to four epidermal growth factor 
receptors in vertebrates; therefore it is a simplified model for studying the EGFR pathway.  
EGFR is a member of the receptor tyrosine kinase family (RTKs). As is characteristic of 
RTKs, EGFR, has a tyrosine amino acid side chain that upon phosphorylation—which is 
catalyzed by the receptor’s kinase domains— causes activation of the pathway. In Drosophila, 
EGFR is activated by four ligands: keren, spitz, and gurken of the TGF-alpha family and vein, a 
neuregulin2. Once bound, the ligands trigger an internal signal transduction pathway that 
activates target genes (Figure 1). This transduction pathway is the RAS/RAF/MEK/MAPK 
pathway. The MAPK kinase activates ETS transcription factors that regulate target genes3. 
When EGFR signaling is received by surrounding cells, they activate or repress responsive genes 
leading to modification of cellular activity4. 
Genetic evidence supports the idea that a number of target genes of EGFR in Drosophila 
act in negative or positive feedback loops that alter the pathway5. Negative inhibitors of the 
EGFR pathway in Drosophila that have been identified include: argos, sprouty, kekkon-1, MAPK 
Phosphatase 3, mae, and d-Cb 6. Positive activators of the EGFR pathway have also been 
identified and include: vein, spitz, pointed, and an miRNA, miR77.  The identification and 
6 
 
analysis of new gene targets of EGFR signaling in our recent publication adds a number of genes 
to these lists8. 
The identification of novel targets of the epidermal growth factor receptor pathway is a 
goal in the Simcox lab. A microarray analysis was done using third instar larvae wing disc RNA. 
The microarray analysis identified 29 previously uncharacterized candidate target genes of 
EGFR. One such gene was CG4096. Following the identification of CG4096 as a candidate 
target of EGFR, in situ hybridization of CG4096 was done on wild type wing discs, wing discs 
under a 71B-GAL4 driver to constitutively over express activated EGFR (71B>EgftTOP), and 
wing discs under 71B-GAL4 driver to constitutively express dominant negative (decreased) 
EGFR signaling (71B>EgftDN). The results of the in situ hybridization supported the findings of 
the microarray analysis. In wild type wing discs, tissue corresponding to future veins showed 
expression (Figure 2, A). Since vein formation is guided by EGFR signaling, it is indication that 
CG4096 is a target in the pathway9. In 71B>EgftTOP wing discs in which the EGFR signaling is 
over expressed, the expression of CG4096 was elevated; this again is indication that CG4086 is a 
target of EGFR signaling (Figure 2, B). In 71B>EgftDN wing discs in which EGFR signaling is 
decreased, the expression pattern of CG4096 is decreased; yet another indication that CG4096 is 
a target of the pathway (Figure 2, C).  
The Simcox lab also analyzed RNAi knockdown of CG4096 (Figure 3). After the 
knockdown of CG4096, an extra vein phenotype appeared between the margin and longitudinal 
vein 2 on the wing (Figure 3, B). Because EGFR is induced in ectopic tissue where it is not 
normally expressed, it is indication that CG4096 is part of a negative feedback loop that inhibits 
EGFR signaling10.
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Figure 1: A model of EGFR 
signaling in Drosophila: 
A schematic model of EGFR 
signaling in Drosophila is shown. 
In Drosophila, EGFR is activated 
by three zygotic ligands: keren 
and spitz of the TGF-α family and 
vein, a neuregulin. Because 
gurken (also of the TGF- α family 
only acts in embryos, it is not 
included in the model. Upon 
activation, EGFR triggers an 
intracellular signal transduction 
pathway that activates 
downstream target genes. The 
activation of CG4096 is depicted 
as a downstream target of EGFR 
signaling. CG4096 also functions 
as part of a negative feedback 
loop that inhibits EGFR at the 
level of the ligands.  
 (Butchar et al. 2012) 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 2: In situ hybridization of CG4096 in Drosophila wing discs: 
Upon in situ hybridization of CG4096 in wild type wing discs (A) tissue corresponding to future veins (3 &4) 
showed expression shows expression. Wing discs in which a 71B-Gal4 driver was used to constitutively 
express activated EGFR (B) showed increased expression of CG4096. Wing discs in which a 71B-Gal4 driver 
was used to constitutively express dominant negative EGFR signaling showed decreased expression of 
CG4096. These results indicate that CG4096 is a target of EGFR signaling in Drosophila. 
 
 
 
 
 
 
 
  
(Butchar et al. 2012) 
 
 
Figure 3: RNAi knockdown of CG4096: 
Wild type wings showed normal expression of EGFR signaling (A). After RNAi knockdown of 
CG4096 (using an Actin-Gal4 driver), an extra vein phenotype was visible between the margin and 
longitudinal vein 2 (B). The ectopic expression of EGFR in tissue where it is not normally expressed 
indicates that CG4096 is part of a negative feedback loop that acts to inhibit EGFR signaling.  
 
 
 
 
 
 
 
 
 
 
(Butchar et al. 2012) 
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Figure 4: Domain 
Architecture of 
Drosophila and human 
ADAMTS proteins: 
The domain architecture 
of ADAMTS proteins 
CG4096 and CG14869 
are depicted here with 7 
of the homologous 
human ADAMTS 
proteins. Characteristic 
metalloproteinase, 
disintegrin, and 
thrombospondin domains 
of a typical ADAMTS 
protein can be identified 
in the CG4096 amino 
acid sequence. CG4096 
is most similar to 
ADAMTS1 based on 
domain structure.  
 
 (Butchar et al. 2012) 
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Significance & Goals 
 
CG4096 is an ADAMTS (A Disintegrin And Metalloproteinase with ThromboSpondin 
motifs) gene in Drosophila with homolog ADAMTS genes in humans (Figure 4)11. There are 19 
ADAMTS genes in mammals which contain specific domains: a signal peptide, a pro-domain, a 
metalloproteinase catalytic domain with a reprolysin-type zinc-binding motif, a disintegrin-like 
domain, a thrombospondin domain, a cysteine-rich domain, a spacer region of variable length,  
and a variable number of C-terminal thrombospondin repeats12. CG4096 is most like ADAMTS1 
and its subfamily (ADAMTS4, 5, 8, 15) based on domain structure13.  Of these CG4096 is most 
similar in sequence to ADAMTS1514. Based on sequence analysis alone CG4096 is most like 
ADAMTS7 and ADAMTS1215. This is significant because the ADAMTS genes have been 
linked to several diseases in humans. By analyzing the role of CG4096 in Drosophila, the role of 
ADAMTS genes in vertebrates may be better understood.  
ADAMTS genes are secreted metalloproteases involved in modification of the 
extracellular matrix16. Substrates of the extracellular matrix that are modified by ADAMTS 
genes include aggrecans, brevicans, proteoglycans, and EGF ligands. Aggrecanases, which 
include ADAMTS-1, -4, -5, -8, and -15, cleave aggrecan, brevican, and versican17. Aggrecan 
loss (and therefore the loss of connective tissue) caused by the uncontrolled proteolysis of 
aggrecans by ADAMTS proteins has been implicated in arthritis18. Similarly, uncontrolled 
proteolysis of brevicans and versicans has been implicated in atherosclerosis19. In atherosclerosis 
plaque, formed by coagulation and aggregation of platelets, builds in the arteries. Over time the 
obstruction of blood flow by the plaque can cause the arteries to rupture resulting in a myocardial 
infarction commonly known as a heart attack.  ADAMTS1 and ADAMTS4 play a positive role 
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in the formation of plaque because of their ability to cleave versican20. When versican is cleaved 
it allows vascular smooth muscle cells to migrate and contribute to the plaque forming in the 
arteries21. While there are many human diseases linked to ADAMTS protein cleavage, the most 
connected to this thesis is that uncontrolled modification of EGF ligands has been implicated in 
cancer— as described in the next section22. 
In cancer, ADAMTSs facilitate metastasis through the degradation of the extracellular 
matrix. Interestingly, ADAMTSs can act as tumor promoters or inhibitors.  ADAMTS1, 
ADAMTS12 and ADAMTS15 act as tumor suppressors in prostate, colon, and breast cancer23. 
In mammals, ADAMTS1 may act as a tumor suppressor by sequestering ligands24.  Because 
CG4096 is part of a negative feedback loop, the gene may act a tumor suppressor (like 
ADAMTS-1) to inhibit ligands binding to EGFR25.  Because of the implication of ADAMTS 
genes in human diseases, I am interested in further analyzing the functional relationship between 
CG4096 and the EGFR pathway.  
The first aim of my thesis is to verify CG4096 as a transcriptional target of EGFR 
signaling. This was done using Schneider 2 Drosophila melanogaster (S2) cells that are easily 
cultured and used to study the expression of proteins in Drosophila. S2 cells are stably 
transfected with epidermal growth factor receptor under a metallothionein promoter. These cells 
are referred to as DER II cells and are induced to express the transgene using CuSO4. 
Comparison of the amount of RNA that corresponds to CG4096 expression between S2 and 
DERII cells indicates whether a gene is a target specifically in the EGFR pathway. Identifying 
CG4096 as a transcriptional target of EGFR signaling in DERII cells indicates that CG4096 as a 
target of EGFR is not merely a local phenomena in the Drosophila wing disc.  
The second aim of my project is to study the phenotypic effects of CG4096 by producing 
a null mutant. A genetic approach is being used to remobilize a transposable P-element inserted 
into the gene in the intron before the first translational start point. (Figure 5). Mobilization of the 
P-element with a transposase causes both precise and imprecise excisions. An imprecise excision 
of the P-element removes not only the P-element but also part of the CG4096 gene; this produces 
a null mutant.  
 
 
 
 
Figure 5: Map of the insert site of EPgy2 in the intron of CG4096 in Drosophila:  
The P-element insert is located in the 20 kb intron of CG4096 on the X chromosome 200 bp away from the first 
exon. Primers have been designed 500 bp from the first insertion site on either side to identify a precise or imprecise 
excision. A precise excision will therefore produce a 1kb band. An imprecise excision in the 1kb span will show a 
smaller band; however, if the imprecise excision is outside the 1kb range, no band will be present. 
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Material & Methods 
 
RT-PCR: 
S2 and S2-DER cells were serum starved overnight (16 hours) to slow the growth process and 
allow for the maximum amount of induced transcription. The cells were then treated with CuSO4 
(final concentration 700 µM) for 9 hours. Total RNA was extracted from the cells using a Qiagen 
RNeasy kit. The RNA was then used in a Reverse transcription (RT) using an Omniscript RT kit 
(Qiagen) to generate the complimentary cDNA. The product of the RT reaction was used as a 
template for PCR reactions using gene specific primers for 25 cycles. Ornithine decarboxylase 
(Oda) was used as a control in the reaction because it is expressed at equal levels in all cells. The 
primers used were as follows: 
CG4096: 5’-CCAGGGTGCCACCTACAAG-3’ (forward) 
5’-GAGAATGTGCCGCGC-3’ (reverse) 
CG14869: 5’- GAGTCACGATGCAGTAC-3’ (forward) 
5’-AACCTTGACACCCTGG-3’ (reverse) 
Oda; 5’-GTCCTTCGGTAGAGCGACAT-3’ (forward) 
5’-GCACCATCTCGACTTCGTCT-3’ (reverse) 
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Stocks:  
The following gene alleles were used to generate an excision of the P-element: y1 w67c23 
P{EPgy2}CG4096EY02397, w+/y ; ; Sb(Δ2-3)/TM6, Tb1, and PG142/FM7.These stocks were 
grown at 25°C.  
 
PCR Based Genotyping: 
Genomic DNA was extracted from females carrying a precise excision using a protocol 
from the Asano Lab. Gene specific primers were used to amplify a region of 1kb (500 bp away 
from the insertion site of the p-element on each side) if a precise excision had occurred. The 
primers were as follows: 
CG4096 deletion mapping primers:  5’- GTCATCGCACTGACGGAG- 3’ (Forward) 
5’- TCAGCAGCATGGCAGC -3’ (Reverse) 
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Results & Discussion 
 
Induction of EGFR in S2-DERII cells causes the expression of CG4096 and 
CG14869: In order to validate the previous discovery of CG4096 as a target gene of EGFR 
signaling, an in vitro analysis using RT-PCR was conducted using RNA extracted from S2 and 
S2-DERII cells. After serum starvation, S2 and S2-DERII cells were induced with CuSO4. 
Induction leads to the expression of target genes of the EGFR pathway. Upon reverse 
transcription and PCR using gene specific primers the expression of CG4096 is only visible in 
S2-DERII cells induced with CuSO4 (Figure 6, row 1; lane 4 (I)). The expression of CG4096 is 
not visible in uninduced S2 cells, induced S2 cells, or uninduced S2-DERII cells (Figure 6: row 
1; lane 1 (UI), lane 2(I), and lane 3(UI)). The expression of CG4096 in S2-DERII cells indicates 
that CG4096 is a transcriptional target of EGFR signaling. The identification of CG4096 as a 
transcriptional target of EGFR signaling in S2-DERII cells is an important discovery because it 
shows that the expression of CG4096 is not a tissue specific phenomenon. Therefore, the 
overexpression of EGFR signaling resulting in the increased expression of CG4096, an 
ADAMTS gene, may be involved in disease in vertebrates. Homologous genes to CG4096 in 
humans, ADAMTS1 and ADAMTS15, have been shown to be overexpressed in cancer which 
makes the finding of CG4096 as a target of EGFR signaling even more interesting.  
Induction of S2 and S2-DERII cells was done in parallel with gene specific primers to 
express CG14869, another ADAMTS gene in Drosophila. The expression of CG14869 is seen at 
a more robust level in induced S2-DERII cells (Figure 6, row 2; lane 4 (I)). Although CG14869 
expression can be seen in uninduced S2-DERII cells (Figure 6, row 2; lane 3 (UI)) (indicating 
that it is also a target of another signaling pathway or that the inhibition of EGFR is leaky), the 
increased expression under induced EGFR signaling is indication that CG14869 is also a 
transcriptional target of EGFR signaling. Further genetic analysis of CG14869, may shed more 
light on the role of CG14869 and its relationship with EGFR. 
Oda, a gene expressed equally in all cells, was used as a control in the RT-PCR analysis 
of CG4096 and CG14869. Oda was expressed in uninduced S2 cells, induced S2 cells, 
uninduced S2-DERII cells, and induced S2-DERII cells (Figure 6, row 3; lane 1 (UI), lane 2 (I), 
lane 3(UI), lane 4 (I)). The expression of Oda equally across cell types indicates that our 
experimental approach was valid.  
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Identification of a Candidate  
Null Mutant of CG4096:  
 
      Figure 6:  Results of RT-PCR in S2 and S2-
DERII Drosophila cells:  
      The expression of CG4096 is present in lane 4 
(I) pertaining to S2-DERII cells induced with 
CuSO4. These results indicate that CG4096 is a 
transcriptional target of EGFR. Lane 1 (UI) shows 
uninduced S2 cells while lane 2 (I) shows induced 
S2 cells. Lane 3 (UI) shows uninduced S2-DERII 
cells. The expression of CG4096 is not evident in 
S2 cells or in uninduced S2-DERII cells.  
      The expression of CG14869 is present in 
uninduced S2-DERII cells, but a more robust 
expression of CG14869 is evident in induced S2-
DERII cells. This indicates that CG14869 is a 
transcriptional target of EGFR signaling, but it is 
also able to be expressed by alternate pathways at 
low levels when EGFR is not induced.  
      Oda , the control, is expressed equally in all four 
cell types. This indicates that the experimental 
procedure is valid.  
 
Identification of a candidate null mutant of CG4096: 
Genetic Cross:  
Virgin females from the y1 w67c23 P{EPgy2}CG4096EY02397 stock with the P-element insert 
were crossed to w+/y ; ; Sb(Δ2-3)/TM6, Tb1 males that carried the transposase. P-elements are 
mobilized in the male progeny with a transposase from this cross (genotype CG4096{EPgy2}/Y; 
; Sb(Δ2-3)/TM6, Tb1). These males were crossed to virgin females from the PG142/FM7 stock. 
White eyed female progeny from this cross resulting from excision of the P-element insert 
(genotype –( )—/FM7) were crossed to males from the FM7 stock. Male progeny from this cross 
with the excision of the P-element (genotype –(  )—/ Y ) were scored for a phenotype which 
could be indicative of an imprecise excision.  
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Figure 7: Genetic Cross to produce 
an imprecise excision of Drosophila 
P-element:  
       Females with a transposable P-
element inserted into the first intron of 
CG4096 (characterized by red eyes) 
were crossed to males carrying the 
transposase (characterized by short 
bristles). Male progeny from this cross 
carrying the P-element and the 
transposase were selected 
(characterized by having orange eyes 
and short bristles); the P-element is 
mobile. These males were crossed to 
FM7/PG142 females. Female progeny 
carrying the excision of the p-element 
(characterized by white eyes) were 
selected and crossed to FM7 males. 
The male progeny from this cross 
were scored for a phenotype that 
would indicate an imprecise excision 
of the P-element and therefore yield a 
null mutant of CG4096. 
;  ;
+
+
‐‐{   }‐‐
Phenotypic Scoring: 
Male progeny with the excision of the P-element were scored for a phenotype that would 
indicate an imprecise excision of the insert and be potential loss of function mutants of CG4096. 
Only males were scored because CG4096 is on the X-chromosome; phenotypic effects would be 
seen in hemizygous males and not heterozygous females with one normal copy of the gene. Male 
progeny were scored for an extra vein phenotype which would be indication of ectopic 
expression of EGFR signaling due to the lack of the negative feedback loop maintained by 
CG4096. A total of 134 excision events were analyzed.  
Of the 134 excision events set up through a genetic screen, 134 showed no visible 
phenotype. There was, however, a candidate mutant that produced no males of the excision 
phenotype. This candidate produced 15 females with the excision, 7 FM7 females, and 16 FM7 
males. This candidate, therefore, could harbor a lethal phenotype as the result of an imprecise 
excision of the P-element and a resulting mutation in the CG4096 gene.  
Table 1: Phenotypes of Excision Events 
 
 Of the 134 excision events analyzed for a phenotype, 0 showed a visible phenotype. There was one lethal candidate that yielded 0 males with an excision of the P-element. This could suggest an imprecise excision 
of the P-element that caused a lethal null mutant of CG4096. The lethal candidate gave 15 females with an 
excision, 7 FM7 females, and 16 FM7 males suggesting it was a healthy and viable cross.  
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PCR based genotyping of a precise excision: 
Gene specific primers were designed 500 bp from the original insertion site of the P-
element of CG4096 (insert located at X:5,596,544). Genomic DNA was extracted from females 
containing the  PCR based genotyping of the genomic DNA showed a precise excision with the 
expected length of 1kb. This indicates that the method of mobilizing the P-element, as well as the 
primer design, is valid. PCR based genotyping of females from the candidate for an imprecise 
excision have yet to be genotyped, so the location of the imprecise excision of the P-element 
inserted into CG4096 is currently unknown.  
Figure 8: Precise excision of 
transposable P-element: The P‐element 
has been excised from CG4096 in the 
genetic screen by a transposase.  PCR 
based genotyping of a female carrying a 
precise excision indicates a precise 
excision at a base length of 1kb.  
 
 
 
 
 
 
 
 
 
19 
 
20 
 
                                                           
References 
 
1 Shilo, Ben‐Zion. Regulating the Dynamics of EGF Receptor Signaling in Space and Time. Development 2005 132 
(18), 4017‐4027. 
2 Shilo 2005. 4017‐4027 
3 Shilo 2005. 4017‐4027 
4 Shilo 2005. 4017‐4027 
5 Avraham, R., and Y. Yarden, 2011 Feedback regulation of EGFR signaling: decision making by early and delayed 
loops. Nat Rev Mol Cell Biol 12: 104‐117. 
6 Butchar, J. P., D. Cain, S. Manivannan, A. D. McCue, L. Bonanno, S. Halula, S. Truesdell, C. Austin, T.L. Jacobsen 
and A. Simcox, 2012. New negative feedback regulators of Egfr signaling in Drosophila. Genetics/2012/141093 
7 Butchar et al. 2012 Genetics. 
8 Butchar et al. 2012 Genetics. 
9 Butchar et al. 2012 Genetics. 
10 Butchar et al. 2012 Genetics. 
11 Apte, S.S., Disintegrin‐like and metalloprotease (reprolysin‐type) with thrombospondin type 1 motif (ADAMTS) 
superfamily: functions and mechanisms. J Biol Chem, 2009, 284, 31493‐31497. 
 
12 Porter, S., I. M. Clark, L. Kevorkian and D. R. Edwards, 2005 The ADAMTS metalloproteinases. Biochem J 386: 15‐
27. 
13 Butchar et al. 2012 Genetics. 
14 Butchar et al. 2012 Genetics 
15 C. Nicholson, S. B. Malik, J. M. Logsdon, Jr. and E. G. Van Meir, Functional evolution of ADAMTS genes: evidence 
from analyses of phylogeny and gene organization BMC Evol Biol, 2005, 5, 11. 
16 S. Porter, I. M. Clark, L. Kevorkian and D. R. Edwards, Biochem J, 2005, 386, 15‐27. 
17 S. Porter, I. M. Clark, L. Kevorkian and D. R. Edwards, Biochem J, 2005, 386, 15‐27. 
18 Apte, S.S., J Biol Chem, 2009, 284, 31493‐31497. 
19 Apte, S.S., J Biol Chem, 2009, 284, 31493‐31497. 
20 Salter, R.C., T.G. Ashlin, A.P. Kwan and D.P. Ramji, 2010 ADAMTS proteases: key roles in atherosclerosis? J Mol 
Med (Merl) 88: 1203‐1211. 
21 Salter, R.C et al. J Mol Med (Merl) 2010, 88: 1203‐1211. 
22 Apte, S.S., J Biol Chem, 2009, 284, 31493‐31497. 
23 Butchar et al. 2012 Genetics 
 
24 Liu, Y. J., Y. Xu and Q. Yu, Full‐length ADAMTS‐1 and the ADAMTS‐1 fragments display pro‐ and antimetastatic 
activity, respectively. Oncogene,2006, 25:2452‐2467. 
25 Butchar et al. 2012 Genetics 
